Table 3.
Change in frequency of nocturia at weeks 6, 12, 18, and 24.
Study time point | RCT Fem™ UI Mean ± SD (n) Within-group p* | PollenBerry® Mean ± SD (n) Within-group p* | Placebo Mean ± SD (n) Within-group p* | p RCT Fem™ UI vs. placebo* PollenBerry® vs. placebo* |
---|---|---|---|---|
Change from baseline at week 6 | −0.06 ± 1.11 (32) 0.75 | 0.15 ± 0.87 (33) 0.32 | 0.18 ± 1.45 (38) 0.44 | 0.42 0.91 |
Change from baseline at week 12 | −0.32 ± 0.98 (29) 0.08 | 0.16 ± 0.93 (31) 0.34 | −0.24 ± 0.88 (38) 0.11 | 0.71 0.08 |
Change from baseline at week 18 | −0.17 ± 2.22 (29) 0.68 | −0.25 ± 0.75 (28) 0.09 | −0.21 ± 0.81 (38) 0.12 | 0.93 0.84 |
Change from baseline at week 24 | −0.52 ± 1.26 (25) 0.05† | −0.12 ± 0.74 (24) 0.42 | −0.38 ± 0.89 (37) 0.01† | 0.63 0.23 |
*The p values for between-group and within-group differences were generated using linear mixed-effects models.
†Indicates a significant within-group difference from baseline.
SD = standard deviation; UI = urinary incontinence.